US 9562073
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted A61KA61K2039/505A61K47/65
Quick answer
US patent 9562073 (Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 51
- CPC classes
- A61K, A61K2039/505, A61K47/65, A61K47/6835, A61K47/6889